Technical Articles
Recent Articles
How Atypical PKCζ Regulates Path...
Roles of Serine/Threonine Phosph...
Histone Crotonylation: Reshaping...
Is There an Inevitable Link Between PD-1 Antibody Half-Life and Clinical Effi...
Recent Advances I. Why Do Antibody-Based Drugs Have Unique Pharmacokinetic Characteristics? The in vivo processes of protein-based drugs are fundamentally different from those of traditional small-molecule drugs. Due to...
Is There an Inevitable Link Between PD-1 Antibody Half-Life and Clinical Effi...
Recent Advances I. Why Do Antibody-Based Drugs Have Unique Pharmacokinetic Characteristics? The in vivo processes of protein-based drugs are fundamentally different from those of traditional small-molecule drugs. Due to...
Read More
A Guide to Anti-Idiotypic Antibodies: From Definition, Classification to Cust...
I. Definition of Anti-Idiotypic Antibodies The idiotype refers to the totality of unique antigenic determinants present on an antibody molecule. A single antibody molecule can possess multiple idiotypic determinants, reflecting...
A Guide to Anti-Idiotypic Antibodies: From Definition, Classification to Cust...
I. Definition of Anti-Idiotypic Antibodies The idiotype refers to the totality of unique antigenic determinants present on an antibody molecule. A single antibody molecule can possess multiple idiotypic determinants, reflecting...
Read More
Plasma p-tau231 Antibodies: Can They Become a New Tool for Early Pathological...
I. Research Background and Significance: Why are new AD biomarkers needed? The pathological process of Alzheimer's Disease begins years or even decades before clinical symptoms appear. Therefore, developing biomarkers...
Plasma p-tau231 Antibodies: Can They Become a New Tool for Early Pathological...
I. Research Background and Significance: Why are new AD biomarkers needed? The pathological process of Alzheimer's Disease begins years or even decades before clinical symptoms appear. Therefore, developing biomarkers...
Read More
Ubiquitination Antibodies: How to Precisely Select the Appropriate Clone Base...
Recent Advances I. Molecular Mechanisms and Functional Diversity of Ubiquitination Ubiquitination, a highly conserved post-translational modification process in eukaryotic cells, involves a three-step enzymatic cascade comprising E1 activating enzymes,...
Ubiquitination Antibodies: How to Precisely Select the Appropriate Clone Base...
Recent Advances I. Molecular Mechanisms and Functional Diversity of Ubiquitination Ubiquitination, a highly conserved post-translational modification process in eukaryotic cells, involves a three-step enzymatic cascade comprising E1 activating enzymes,...
Read More
Acetylation Antibodies: How Do They Reveal the Key Role of N-terminal Acetyla...
Recent Advances I. What Are the Unique Characteristics of N-terminal Acetylation Modification? Protein N-terminal acetylation is one of the most prevalent post-translational modifications in eukaryotes, occurring with a frequency exceeding...
Acetylation Antibodies: How Do They Reveal the Key Role of N-terminal Acetyla...
Recent Advances I. What Are the Unique Characteristics of N-terminal Acetylation Modification? Protein N-terminal acetylation is one of the most prevalent post-translational modifications in eukaryotes, occurring with a frequency exceeding...
Read More
Single-Cell and Spatial Transcriptomics Reveal the Key Axis of PTMC Progression
Recently, a landmark study on the progression mechanism of papillary thyroid microcarcinoma (PTMC) was published in Advanced Science (2025). The team from China Medical University, using multi-technical approaches such as single-cell...
Single-Cell and Spatial Transcriptomics Reveal the Key Axis of PTMC Progression
Recently, a landmark study on the progression mechanism of papillary thyroid microcarcinoma (PTMC) was published in Advanced Science (2025). The team from China Medical University, using multi-technical approaches such as single-cell...
Read More